The Patent Finder

Acure Pharma AB

Also on record
Records under this name other than patents Acure Pharma AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Acure Pharma AB

PatentTitleStatus Expires Confidence
US 8,372,878Aminoguanidines as melanocortin receptor ligands
Formerly held
Lapsed on the fee record
Ended Feb 12, 2021 · From the USPTO record
Lapsed on the fee recordEnded Feb 12, 2021From the USPTO record
US 8,309,609Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
Formerly held
Lapsed on the fee record
Ended Nov 13, 2020 · From the USPTO record
Lapsed on the fee recordEnded Nov 13, 2020From the USPTO record
US 8,227,502Amides acting on the adenosine receptors
Formerly held
Lapsed on the fee record
Ended Jul 24, 2020 · From the USPTO record
Lapsed on the fee recordEnded Jul 24, 2020From the USPTO record
US 8,148,429Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
Formerly held
Lapsed on the fee record
Ended Apr 3, 2020 · From the USPTO record
Lapsed on the fee recordEnded Apr 3, 2020From the USPTO record
US 7,153,881Compounds acting as melanocortin receptor ligands
Formerly held
Lapsed on the fee record
Ended Dec 26, 2018 · From the USPTO record
Lapsed on the fee recordEnded Dec 26, 2018From the USPTO record
US 6,518,246Pharmaceutical composition and method for the treatment of neoplastic cells
Lapsed on the fee record
Ended Feb 11, 2015 · From the USPTO record
Lapsed on the fee recordEnded Feb 11, 2015From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited